![]() | Up a level |
Journal Article
Nanni, Cristina, Cottereau, Anne Segolene, Lopci, Egesta ORCID: 0000-0001-9732-1094, Bodet-Milin, Caroline
ORCID: 0000-0002-8219-3592, Coronado, Monica, Pro, Barbara, Kim, Wong Seog, Trotman, Judith
ORCID: 0000-0001-8009-4593, Barrington, Sally, Duhrsen, Ulrich, Vander Borght, Thierry, Zamagni, Elena
ORCID: 0000-0003-1422-7305, Kraeber-Bodere, Francoise
ORCID: 0000-0002-3417-0759, Messiou, Christina
ORCID: 0000-0002-0557-9379, Rahmouni, Alain, Buvat, Irene
ORCID: 0000-0002-7053-6471, Andre, Marc, Hertzberg, Mark, Oyen, Wim, Casasnovas, Olivier, Luminari, Stefano
ORCID: 0000-0001-8446-2285, Garderet, Laurent, Montravers, Francoise, Kobe, Carsten, Kluge, Regine, Versari, Annibale
ORCID: 0000-0002-8675-2435, Zucca, Emanuele
ORCID: 0000-0002-5522-6109, Moreau, Philippe, Cheson, Bruce, Haioun, Corinne
ORCID: 0000-0003-0095-5379, Gallamini, Andrea and Meignan, Michel
(2017).
Report of the 6th International Workshop on PET in lymphoma.
Leuk. Lymphoma, 58 (10).
S. 2298 - 2304.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1029-2403
Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., Schorb, Elisabeth, La Rosee, Paul, Binder, Mascha ORCID: 0000-0003-0663-3004, Fabbri, Alberto, Torri, Valter
ORCID: 0000-0001-9541-9354, Minacapelli, Eleonora, Falautano, Monica, Ilariucci, Fiorella, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire, Johnson, Peter
ORCID: 0000-0003-2306-4974, Linton, Kim M., Pukrop, Tobias, Gorlov, Jette Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jens, Tucci, Alessandra
ORCID: 0000-0003-3052-7463, Orsucci, Lorella, Pisani, Francesco, Levis, Alessandro, Krause, Stefan W., Schmoll, Hans J., Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Pfreundschuh, Michael, Cabras, Giuseppina, Angrilli, Francesco, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Juergen, Reni, Michele, Cavalli, Franco, Zucca, Emanuele
ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald
(2017).
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
Lancet Haematol., 4 (11).
S. E510 - 14.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2352-3026
Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elko, Ponzoni, Mourilio, Deckert, Martina, Politi, Letterio S., Torri, Valter ORCID: 0000-0001-9541-9354, Fox, Christopher P., La Rosee, Paul
ORCID: 0000-0002-6758-7809, Schorb, Elisabeth, Ambrosetti, Achille, Roth, Alexander, Hemmoway, Claire, Ferrari, Angela
ORCID: 0000-0002-9984-1146, Linton, Kim M., Ruda, Roberta, Binder, Mascha
ORCID: 0000-0003-0663-3004, Pukrop, Tobias, Balzarotti, Monica, Fabbri, Alberto, Johnson, Peter, Gorlov, Jette Sonderskov, Hess, Georg, Panse, Jens, Pisani, Francesco, Tucci, Alessandra
ORCID: 0000-0003-3052-7463, Stilgenbauer, Stephan, Hertenstein, Bernd, Keller, Ulrich, Krause, Stefan W., Levis, Alessandro, Schmoll, Hans J., Covalli, Franco, Finke, Jurgen, Reni, Michele
ORCID: 0000-0002-6463-0293, Zucca, Emanuele
ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald
(2016).
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Lancet Haematol., 3 (5).
S. E217 - 11.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2352-3026